“Activated mast cells” was positively associated with SBDS and ANGPTL4 but negatively associated with ICOS, suggesting that the infiltration levels of activated mast cells (MCs) were increased in the high-risk group of CSCC patients. Here, ANGPTL4 is linked to skin squamous cell carcinoma.